Rolling its valuation models to year‑end 2026, Wolfe raised its fair‑value range to $53–$112 a share, compared with Monday’s $69 close, and said the risk‑reward now tilts positive even though downside ...

Symvess, described as an acellular tissue engineered vessel, received FDA approval for extremity vascular trauma indication in December 2024. The product is part of Humacyte’s commercial-stage ...

Investing.com -- Recursion Pharmaceuticals Inc (NASDAQ: RXRX) stock surged 11.5% while Rallybio Corp (NASDAQ: RLYB) shares ...

SEALSQ has also become an investor and shareholder in WISeSat.Space, a satellite company developing low-orbit satellites for IoT connectivity. Through this partnership, telecommunications operators ...

Investing.com -- President Donald Trump announced on his social media platform Truth Social that tariffs on various countries will begin on August 1, 2025. In his statement, Trump emphasized that ...

As the founding partner, OpenAI is contributing $10 million over five years, including $8 million in direct funding and $2 million in in-kind resources such as engineering support, computing access, ...

MIPS recently launched its Atlas portfolio, a suite of compute cores for real-time processing and AI edge applications, along with Atlas Explorer, a virtual platform for performance optimization.

You know, they want to make sure that everything is proper, because it’s a new, innovative offering, and we’re confident,” ...

Investing.com -- Fair Isaac Corporation (NYSE: FICO) stock fell 6% today while Equifax (NYSE: EFX) shares rose 3% and ...

“Value funds generated the most alpha (+60bp on avg., 70% hit rate),” BofA noted. Growth funds also performed well, with a 60 ...

Investing.com -- A+E Global Media is exploring strategic options, including a potential sale or merger, and has hired Wells Fargo (NYSE: WFC) to assist with this process, according to report from ...

Investing.com - S&P 500 dividend yields are now hovering around a record low, according to analysts at Deutsche Bank (ETR: ...